Announcements
Blog
Innovative Humanitarian Financing Forum charts way forward
Leaders in business and philanthropy explore pathways to catalyse change through public-private financing. How can public and private sectors work together to increase the scale and scope of funding required to proactively address social causes - and potentially avert crises from future global threats?
IFFIm stands ready to support COVID-19 vaccines
Fast, flexible financing could be a game-changer in fighting the virus.
Public and private sector leaders plant seed for forum on innovative finance for humanitarian purposes
London, 16 March 2020 - Participants from 13 organizations ranging from legal and investment firms to Gavi, IFFIm, Red Cross, the UN and the World Bank gathered in central London on March 2 to explore creating a forum for public and private users of innovative finance. During this initial roundtable discussion, participants from the development, fi...
IFFIm Vaccine Bond issuance named 2019 "Deal of the Year" by mtn-i
London, 6 February 2020 - IFFIm, Skandinaviska Enskilda Banken (SEB) and the Toronto-Dominion Bank have been awarded SRI “Deal of the Year” by news, data and analytics publisher mtn-i for a July 2019 Vaccine Bond issuance that raised funding to research and develop new vaccines. The award was given in the SRI: Green/Social category for IFFIm’...
The Edge of Innovative Finance
A conversation with Christopher Egerton-Warburton Christopher Egerton-Warburton, or Edge, as he’s known throughout the financial world, was in the room where it happened, when IFFIm began in 2006. Edge is the Co-Founder and Partner of Lion's Head Global Partners LLP and served for six years on the IFFIm Board of Directors. He is an expert in the s...
How Japanese investors primed a global market for vaccine bonds
From an acclaimed debut Uridashi to the latest investment by Dai-ichi Life, Japanese investors set a trend for socially responsible investing Leaders from the global health community are convening this week at the Seventh Tokyo International Conference on African Development (TICAD), where Gavi, the Vaccine Alliance is unveiling its Investment Opp...
World Immunization Week highlights IFFIm's game-changing innovations
Since 2006, IFFIm has contributed US$ 2.6 billion to Gavi’s immunisation programmes and had a catalytic effect on increasing uptake of underused vaccines in the poorest countries. Making sure that vaccines reach as many children as possible around the world requires a healthy dose of innovation. During World Immunization Week 2019, IFFIm and Gavi ...
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.